Protagenic Therapeutics Inc (NASDAQ:PTIX)

0.63
Delayed Data
As of Sep 27
 0.00 / 0.00%
Today’s Change
0.56
Today|||52-Week Range
2.35
-54.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization0.00534.00148.00347.00
 
 
 
 
 
Operating ExpensesGross Income0.00-534.00-148.00-347.00
 
 
 
 
General Expenses975.0K1.8M2.4M2.3M
 
 
 
 
 
Research And Development42.0K533.7K717.5K881.2K
 
 
 
 
 
Total Operating Expenses975.0K1.8M2.4M2.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-975.0K-1.8M-2.4M-2.3M
 
 
 
 
 
Extraordinary Credit574.0K0.0091.0K0.00
 
 
 
Extraordinary Charge-204.0K-433.6K0.00-250.2K
 
 
 
 
Interest Expense On Debt3.0K7.2K0.000.00
 
 
 
Other Expenses54.0K-6.6K770.004.1K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-350.0K-2.3M-2.3M-2.6M
 
 
 
 
 
Minority Interest-49.0K0.000.000.00
 
 
Net Income-301.0K-2.3M-2.3M-2.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS25.9K5.3M10.3M10.3M
 
 
 
 
 
Shares To Calculate EPS Diluted25.9K5.3M10.3M10.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$11.60-$0.43-$0.22-$0.25
 
 
 
 
 
EPS Diluted-$11.60-$0.43-$0.22-$0.25